Blue Horizon International Email Format

Medical PracticesNew York, United States11-50 Employees

Blue Horizon International provides stem cell therapies for adults and children, including cord blood, bone marrow, and adipose-derived treatments. The organization reports having completed more than 4,000 stem cell therapies to date. It holds a license from the Slovak Ministry of Health to offer cord blood, bone marrow, and adipose-derived therapies at Malacky Hospital near Bratislava. Founded in 2009, Blue Horizon International operates as a healthcare consulting company that combines treatment, research, and philanthropy.

The therapies are supported by research and safety protocols, including studies published in peer-reviewed journals and presented at conferences, with development conducted under Good Tissue Practice and Good Clinical Practice. The company notes that its cellular products have demonstrated safety and potential for symptom improvement across chronic inflammation, spinal cord injury, stroke, and musculoskeletal disorders, and it has obtained FDA authorization to pursue an Investigational New Drug study of a cord blood therapy for acute ischemic stroke, registered on ClinicalTrials.gov.

Get verified Blue Horizon International emails free

Company overview Employee directory